United States trails Europe in Biosimilar drug approval numbers: Biosimilars Council White Paper

2018-06-13 09:36:17

A new Biosimilars Council report, titled, ‘Breaking Through on Biosimilars: Delivering More-Affordable, Innovative Medicines for America’s Patients’, recommends policies to fulfill promise of biosimilars in the US. By Team ABLEA new Biosimilars Council report, titled, ‘Breaking Through on Biosimilars: Delivering More-Affordable, Innovative Medicines for America’s Patients’, recommends

Read more

Diagnostics startup Theranosis bags Mumbai Angels Network’s investment

2018-06-12 09:28:55

Theranosis Life Sciences has raised an undisclosed amount from Mumbai Angels Network.By Team ABLEDiagnostics startup Theranosis Life Sciences Pvt. Ltd, which focuses on the oncology space, has raised an undisclosed amount from Mumbai Angels Network. The Hyderabad-based startup, which was founded by Shibichakravarthy Kannan and Vennila Dharman in 2016, deals with non-invasive diagnostics for cancer

Read more

H D Kumaraswamy’s Government names K J George as IT, BT and ST Minister

2018-06-12 09:27:58

Congress legislator Mr K J George is the minister for  Karnataka’s Large and Medium Scale Industries , IT, BT, Science and Technology.By Team ABLECongress MLA Kelachandra Joseph George will head the portfolio of Information Technology, Biotechnology and Science and Technology (IT, BT and ST) in Karnataka. Minister George will also handle the Ministry of Social Welfare as an additional portf

Read more

AIIMS researchers discover Type 4 Diabetes; discovery to aid Glaucoma cure

2018-06-11 09:03:37

Researchers at the All India Institute of Medical Sciences (AIIMS) have discovered and described a new type of diabetes called Type 4 Diabetes, which specifically affects the eye and brain tissues.By Team ABLEResearchers at the All India Institute of Medical Sciences (AIIMS) have discovered and described a new type of diabetes called Type 4 Diabetes, which specifically affects the ocular (eye) and

Read more

Cipla to market Eli Lilly’s diabetes drug Basaglar

2018-06-11 09:02:13

Cipla will market and distribute Basaglar, the once-daily insulin glargine therapy for the treatment of patients with type 1 & 2 diabetes above two years of age. By Team ABLECipla will market and distribute Basaglar, the once-daily insulin glargine therapy for the treatment of patients with type 1 & 2 diabetes above two years of age. Cipla Limited has partnered with Eli Lilly and Company,

Read more

BIO 2018 Convention draws 18,289 global biotechnology industry leaders; sets Guinness Record for maximum partnering meetings

2018-06-08 09:10:37

Setting a Guinness World Record for “The Largest Business Partnering Event,” BIO 2018 hosted 46,916 partnering meetings, facilitated by BIO’s One-on-One Partnering system — a 13% increase over 2017.By Team ABLEThe 2018 BIO International Convention (BIO 2018) was wrapped up after four days of programming under the theme of “Make History.” Hosted by the Biotechnology Innovation Orga

Read more

India, Norway sign MoU to extend health cooperation

2018-06-08 09:09:01

This cooperation between India and Norway is aligned with the development goals of Government of India as outlined in its National Health Policy 2017By Team ABLEIndia’s Ministry of Health and Family Welfare has signed a Memorandum of Understanding (MoU) with the Norwegian Ministry of Foreign Affairs, Government of Norway to extend the cooperation within health sector through the Norway India Par

Read more

Government’s budget allocation for Department of Biotechnology boosted by 65% during the last four years

2018-06-08 09:07:44

The investment in Science, Technology and related areas has gone up during the last four years starting 2014-15 to 2018-19, as against five years earlier, i.e., 2009-10 to 2013-14. The budget allocation to Department of Science & Technology was Rs. 19,764 crores, which is a 90% increase. Similarly, there was an increase of 65% for the Department of Biotechnology. By Team ABLEThe Union Minister

Read more

Contract research company AMRI bags seven-year NIH contract

2018-06-08 09:04:24

AMRI\'s activities under the contract will focus on the development and manufacture of active pharmaceutical ingredients (API) and drug product for Phase I clinical studies.By Team ABLEAMRI, a global contract research, development and manufacturing organization, has secured a seven-year contract from the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes

Read more

Pfizer makes $600 million commitment to Pfizer Ventures; 25% of funding dedicated to Neuroscience study

2018-06-08 09:03:26

Pfizer Inc. has announced its plans to invest $600 million in biotechnology and other emerging growth companies through Pfizer Ventures. By Team ABLEPfizer Inc. has announced its plans to invest $600 million in biotechnology and other emerging growth companies through Pfizer Ventures, the company’s venture investment vehicle.  In addition to increased funding, Pfizer will extend its leaders

Read more